Back, Spine & Nerves Research
(Protocol) Spinal cord injuries, fortunately, have a relatively low incidence. Nevertheless, it is true that in active working life for the most part victims off guard and represents a catastrophic cut in the social and financial life. It is estimated (depending on the source) that globally between 250,000 to 500,000 people each year an injury, spinal cord, the involved suffer.
Non-specific low back pain is common and affects people of all ages (e.g., Carraggee, 2005; Bhangle et al., 2009; Maher et al., 2017). Non-specific low back pain is defined as low back pain not attributable to a recognizable, known specific pathology (e.g., infection, tumour, osteoporosis, fracture, structural deformity, inflammatory disorder, radicular syndrome, or cauda equina syndrome)
Oxford, UK Non-invasive treatment of herniated discs by focused shock wave therapy – (Non-invasive treatment of herniated discs by focused shockwave therapy) – In orthopedic practice meets a number of pathologies, surgical treatment which is necessary because of the inefficiency of the traditional conservative therapy.
We investigated the effects of extracorporeal shockwave therapy (ESWT) on the rehabilitation of cervical spondylosis with nuchal ligament (NL) calcification under X-ray and ultrasound guidance. Sixty patients with cervical spondylosis and calcification of NL were selected and randomly assigned to three groups: A, B, and C.
Paraplegia following spinal cord ischemia represents a devastating complication of both aortic surgery and endovascular aortic repair. Shock wave treatment was shown to induce angiogenesis and regeneration in ischemic tissue by modulation of early inflammatory response via Toll-like receptor (TLR) 3 signaling.
A randomized controlled trial. Coccydynia is pain in the coccygeal region, and usually treated conservatively. Extracorporeal shock wave therapy (ESWT) was incorporated as non-invasive treatment of many musculoskeletal conditions.
A report of two cases -(Yousef Marwan, MBBS, Wael Husain, MBBS, FRCSC , Waleed Alhajii, MBBS, MSc, Facharztb , Magdy Mogawer, MBBS) – Extracorporeal shock wave therapy (ECSWT) has been used widely for musculoskeletal conditions.
Coccydynia can lead to significant functional disability and worsening of quality of life if not properly managed. In this study, we aim to assess the outcomes of extracorporeal shock wave therapy in patients with coccydynia.
Lumbar facet joints (FJ) is a common source of low back pain and contributes approximmately on one third of chronic low back pain. Medial branch radiofrequency neurotomy is considered as a gold standard in the treatment of facet joint pain. Corticosteroid injections have also presented effect in FJ pain.
Short-term results of a randomized controlled trial. The physiotherapy treatment of low back pain (LBP) with physical stimulation offers different possibilities of application. Until now, the physical therapies used in LBP are laser therapy, ultrasonotherapy and currents.
Previous clinical trials have reported that extracorporeal shock wave (EPSW) can be used to treat low back pain (LBP), and have achieved satisfied effect.
The purpose of the present study was to examine the effects of extracorporeal shockwave therapy (ESWT) for patients with chronic low back pain and their dynamic balance ability. [Subjects] Twenty-eight patients with chronic low back were divided into an extracorporeal shockwave therapy group (ESWTG: n=13) and a conservative physical therapy group (CPTG, n=15).
Peripheral nerve injuries affect millions of people every year. After trauma or surgery, patients often require autologous nerve grafting, which is the “gold standard”, but nevertheless a complex and demanding surgical procedure with low chances of success. The choice of graft type and optimal regeneration conditions are crucial for the final result. Scientists of the Ludwig-Boltzmann-Institute in Vienna rise to the challenge by utilizing Spark Wave Technology which is, due to its cell activating effect in various tissues, a highly emergent technology in the field of regenerative medicine (e. g. in urology and orthopaedics).
Extracorporeal shock wave therapy (ESWT) is widely used in clinical practice. In addition to its original use in kidney stone disintegration, shock waves are now used for the treatment of a variety of regenerative indications. Mechanotransduction stimulates the body’s biological healing processes at the cellular level. In areas of wound healing, orthopaedics or erectile dysfunction, very good, well-founded treatment successes are achieved.
Movement Disorder Center, Rheintalklinik, Bad Krozingen, Germany) – Can stimulation of nerve growth factors by focused transcranial extracorporeal shock wave therapy (TESWT) be made effective for persons within unresponsive wakefulness syndrome.
As new approaches for peripheral nerve regeneration are sought, there is an increasing demand for native Schwann cells for in vitro testing and/or reimplantation. Extracorporeal shockwave treatment (ESWT) is an emergent technology in the field of regenerative medicine that has also recently been shown to improve peripheral nerve regeneration. Methods. In this study, we elucidate the effects of ESWT on Schwann cell isolation and culture.
Shock waves are defined as types of acoustic pressure waves that develop during sudden releases of energy. The best-known natural phenomenon is thunder following lightning. Since the first medical application of acoustic waves was the disintegration of kidney stones in the early 1980’s, high energy, focused shock waves were the first to be studied and understood.
Low energy shock waves have been shown to induce angiogenesis, improve left ventricular ejection fraction and decrease angina symptoms in patients suffering from chronic ischemic heart disease.
Spasticity is the most problematic self-reported secondary medical problem in patients with spinal cord injury. Recently, studies reported positive effects of extracorporeal shock wave therapy on spasticity in patients with stroke, focal limb dystonia and cerebral palsy.
Shock wave therapy (SWT) reportedly improves ventricular function in ischemic heart failure. Angiogenesis and inflammation modulatory effects were described. We hypothesized that SWT modulates inflammation via toll-like receptor 3 (TLR3) through the release of cytosolic RNA.
Stem and progenitor cell therapy is a novel approach to improve neovascularization and function of ischemic tissue. Enhanced tissue expression of chemoattractant factors such as stromal cell–derived factor 1 and vascular endothelial growth factor is crucial for the recruitment of circulating endothelial progenitor cells (EPCs) during acute ischemia. We investigated the effect of targeted extracorporeal shock wave (SW) application in order to facilitate EPC recruitment into nonischemic and chronic ischemic tissue.
Extracorporeal Shockwaves produced consistent biological effects in tendon and bone, and at the tendon-bone interface. The biological mechanism of musculoskeletal shockwaves appeared to stimulate the expressions of angiogenic growth factors and induce the ingrowth of neovascularization.
The results of this nerve transection and repair study show that EWST immediately after surgery is effective – there is improvement of functional recovery.